The clinical study on the safety and effectiveness of Apatinib Mesylate in locally advanced head and neck soft tissue sarcoma with the induction chemotherapy treatment

Trial Profile

The clinical study on the safety and effectiveness of Apatinib Mesylate in locally advanced head and neck soft tissue sarcoma with the induction chemotherapy treatment

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Rivoceranib (Primary)
  • Indications Head and neck cancer; Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top